(Q44985029)

8 December 2017

Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation (English)

1 reference

8 December 2017

mesenchymal stem cell

1 reference

8

Gary Gilkeson

1 reference

8 December 2017

Xiaolei Ma

1

1 reference

8 December 2017

Nan Che

2

1 reference

8 December 2017

Zhifeng Gu

3

1 reference

8 December 2017

Jing Huang

4

1 reference

8 December 2017

Dandan Wang

5

1 reference

8 December 2017

Jun Liang

6

1 reference

8 December 2017

Yayi Hou

7

1 reference

8 December 2017

Liwei Lu

9

1 reference

8 December 2017

Lingyun Sun

10

1 reference

8 December 2017

31 October 2012

1 reference

8 December 2017

1 reference

8 December 2017

22

1 reference

8 December 2017

12

1 reference

8 December 2017

2279-2290

1 reference

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

8 December 2017

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

B cells move to centre stage: novel opportunities for autoimmune disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

B cell abnormalities in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Immunomodulatory effects of fetal and adult mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

BAFF: a fundamental survival factor for B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Marrow stromal cells as stem cells for nonhematopoietic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368912X658692

21 January 2018

Identifiers

DOI

10.3727/096368912X658692

1 reference

8 December 2017

1 reference